Futura Medical

Powerhouse Energy Group announced that CEO Paul Emmitt will step down in September, just as the company moves towards first commercial revenues. Non-executive chairman David Hitchcock will become executive chair until a new CEO is appointed, while Emmitt is expected to continue working with Engsolve on a technical consultancy basis. 2025 revenue jumped to £1.23 million, with losses narrowing. In other AIM news, Quantum Blockchain Technologies reported a 30% mining advantage in live testing for its Method C AI Oracle, though losses widened slightly; the company has since raised fresh cash and extended bond maturities. Futura Medical ended its US partnership with Haleon for erectile dysfunction treatment Eroxon, lining up a new distributor, with Haleon paying a $1.9 million termination fee. ATOME is continuing talks with Paraguay's government and state power firm ANDE to keep its green fertiliser project on track, noting that Villeta could become the country's biggest ever industrial investment. Shares in DeFi Development Corporation UK jumped 83% after it announced a rebrand to Cykel AI alongside a full boardroom overhaul, with new CEO Gerald Tritt taking the reins as the company repositions around artificial intelligence.